OMF at the IIMEC15 in England – Empowering ME/CFS Research and Collaboration
OMF is proud to be one of the sponsors of the 15th Invest in ME Research International ME Conference (IIMEC15).
In mid-2020, Open Medicine Foundation (OMF) launched a three-year study to find answers. We’re leading a large-scale international study following the potential conversion of Post-COVID Syndrome, also known as Long-COVID, to Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS), a chronic, life-altering disease. This study is an unprecedented opportunity to find ME/CFS drug treatments and prevention strategies at an accelerated pace.
As leaders of the largest worldwide nonprofit effort to diagnose, treat, and prevent ME / CFS and related complex diseases, such as Post Treatment Lyme Disease Syndrome and Fibromyalgia, we know one thing to be true: If we don’t do the research now, millions will be left behind. Join us in our mission to find the answers.
“We do know for absolutely certain that there is a post-COVID syndrome…Anywhere from 25% to 35%—or more—have lingering symptoms well beyond what you would expect from any post-viral syndrome like influenza and others. It’s fatigue, shortness of breath, muscle aches, dysautonomia, sleep disturbances, and what people refer to as brain fog.”
Anthony S. Fauci, MD.
Because many people develop ME/CFS after a viral infection, researchers question whether some viruses might trigger the disorder.
Source:Mayo Clinic
In one study, 27% of hospitalized SARS patients met the CDC’s criteria for ME/CFS one year after recovery from SARS itself.
Source:Lam et al. (2009)
About 1 in 10 infected with Epstein-Barr virus, Ross River virus, or Coxiella burnetti develop symptoms that meet the criteria for ME/CFS.
Source: CDC (2018)
History shows us that a documented percentage of those who were sick with a post-viral syndrome will end up developing symptoms of ME/CFS.
have ME/CFS worldwide
are affected in the USA alone
25% are homebound
No FDA approved treatment
No cure
$17 to 24 billion
affected in USA
men, women and children.
Anyone. Any time.
ME/CFS is a debilitating illness that has upended too many people’s lives. With no FDA-approved treatments or cure, millions have been left behind, forced to put their lives on hold as they wait for answers. In the aftermath of COVID-19, millions more are now at risk of developing the disease.
OMF secured a $1 million grant to launch the first year of our three-year international study. It already being conducted across the globe at the OMF funded Collaborative Research Centers spearheaded by some of the world’s top researchers and ME/CFS experts.
We are actively working to raise an additional $2 million to fund the next two years of the study. We all need this research now. We need your help today, so millions can return to health tomorrow.
Too many people already suffer from this debilitating disease, and now millions more are at risk.
OMF is proud to be one of the sponsors of the 15th Invest in ME Research International ME Conference (IIMEC15).
This study seeks to understand the biological mechanisms driving the symptomatology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using metabolomic and lipidomic high-throughput analysis and high-frequency blood sampling over a 6.5 to 7.5 hour period conducted at two separate sites (Melbourne and Uppsala).
As we reach the final hours of our May Momentum campaign, we at Open Medicine Foundation Canada (OMFCA) are reaching out to remind you of
Help us find the answers.
Donate to Open Medicine Foundation today!